Apimeds Pharmaceuticals US, Inc
APUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,781 | -$2,662 | -$402 | -$312 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $17 | -$2,605 | $344 | $176 |
| Other Non-Cash | $36 | $1,906 | $38 | $36 |
| Operating Cash Flow | -$1,726 | -$3,361 | -$20 | -$100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23 | -$13 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$23 | -$13 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $250 | $0 |
| Stock Issued | $0 | $11,953 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$94 | $17 | $77 |
| Financing Cash Flow | $0 | $11,859 | $267 | $77 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,749 | $8,485 | $247 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,735 | $250 | $3 | $27 |
| End Cash | $6,987 | $8,735 | $250 | $3 |
| Free Cash Flow | -$1,749 | -$3,374 | -$20 | -$100 |